Abstract
The purpose of this study was to examine the fatty acid composition and content of phospholipids, and free fatty acids in human heart muscle samples obtained at autopsy from people that died suddenly in accidents and from people that died suddenly from heart disease, with or without coronary artery disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Schwartz, J. M. Wood, J. C. Allen, E. P. Bornet, M. L. Entman, M. A. Goldstein, L. A. Sordahl, M. Suzuki, and R. M. Lewis, Biochemical and morphologic correlates of cardiac ischemia, I Membrane systems, Am. J. Cardiol., 32: 46–61 (1973).
S. Gudbjarnason and G. Oskarsdottir, Modification of fatty acid composition of rat heart lipids by feeding cod liver oil, Biochim. Biophys. Acta, 487: 10–15 (1977).
A. Emilsson and S. Gudbjarnason, Changes in fatty acyl chain composition of rat heart phospholipids induced by noradrenaline. Biochim. Biophys. Acta, 664: 82–88 (1981).
S. Gudbjarnason, G. Oskarsdottir, B. Doell and J. Hallgrimsson, Myocardial membrane lipids in relation to cardiovascular disease, Advances in cardiol., 25: 130–144 (1978).
G. Rouser, G. I. Nelson and S. Fleischer, Lipid composition of animal cell membranes, organelles and organs, in: Biological Membranes, D. Chapman, ed., Academic Press, Vol., 1:5–69 (1968).
S. Gudbjarnason and I. Hallgrimsson, Cardiac lipids and ischemic tolerance, in: “Ischemic Myocardium and Antianginal Drugs”, M. M. Winbury and Y. Abiko, ed., Raven Press p. 213–224 (1979).
J. Dyerberg, H. O. Bang, E. Stofferson, S. Moncada and J. R. Vane, Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis, Lancet, 2: 117–119 (1978).
R. Saynor and D. Verel, Effect of a marine oil high in eicosapentaenoic acid on blood lipids and coagulation, IRCS Medical Science, 8: 378–379 (1980).
S. Gudbjarnason and A. Emilsson, Unpublished observations.
A. S. Blix, J. K. Kjekshus, I. Enge and A. Bergen, Myocardial blood flow in the diving seal, Acta Physiol. Scand., 96: 277–280 (1976).
M. Fry and D. Green, Cardiolipin requirements for electron transfer in complex I and III of the mitochondrial respiratory chain, J. Biol. Chem., 256: 1874–1880 (1981).
O. Colard, A. Kervabon and C. Roy, Effects on adenylate cyclase activities of unsaturated fatty acid incorporation into rat liver plasma membrane phospholipids, Specific modulation by linoleate, Biochem. Biophys. Res. Comm., 95: 97–102 (1980).
E. G. Lakatta, Age-related alterations in the cardiovascular response to adrenergic mediated stress, Fed. Proceed. Vol., 39: 3173–3177 (1980).
V. A. Kurien and M. F. Oliver, A metabolic cause for arrhythmias during acute myocardial hypoxia, Lancet, 1: 813–815 (1970).
M. Schwartzman, E. Liberman and A. Raz, Bradykinin and angiotensin II activation of arachidonic acid deacylation and prostaglandin E formation in rabbit kidney, J. Biol. Chem., 256: 2329–233 (1981).
K. Schr5r, Possible role of prostaglandins in the regulation of coronary blood flow, Basic Res. Cardiol., 76: 239–249 (1981).
L. E. Hokin and T. C. Hexum, Studies on the characterization of the (Na+ + K+) transport adenosine triphosphatase IX, On the role of phospholipids in the enzyme, Archiv. Biochem. Biophys., 151: 453–463 (1972).
R. J. Lefkowitz, Catecholamine stimulated myocardial adenylate cyclase: effects of phospholipase digestion on the role of membrane lipids, J. Molec. Cell, Cardiol, 7: 27–37 (1975).
B. Samuelsson, G. C. Folco, E. Granström, H. Kindahl,-and C. Malmsten, Prostaglandins and thromboxanes: Biochemical and physiological considerations, in: Advances in Prostaglandin and Thromboxane Research Vol. 4, B. Samuelsson, and R. Paoletti, Raven Press, N.Y. pp. 1–25 (1978).
S. Gudbjarnason, and G. óskarsdóttir, Modification of fatty acid composition of rat heart lipids by feeding cod liver oil, Biochim. Biophys. Acta 487: 10–15 (1977).
A. Emilsson, and S. Gudbjarnason, Changes in fatty acyl chain composition of rat heart phospholipids induced by noradrenalin, Biochim. Biophys. Acta 664: 82–88 (1981).
F. Hirata, and I. Axelrod, Phospholipid methylation and biological Transmission, Science 209: 1082–1090 (1980).
S. Gudbjarnason, G. óskarsdóttir, B. Doell, and I. Hallgrímsson, Myocardial membrane lipids in relation to cardiovascular disease, Adv. in Cardiol, 25:130–144 (1978).
F. Z. Meerson, Disturbances of metabolism and cardiac function under the action of emotional painful stress and their prophylaxis, Basic Res. in Cardiol, 75:479–500 (1980).
H. P. Misra, and I. Fridovich, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, J. Biol. Chem., 247: 3170–3175 (1972).
R. A. Heacock, and W. S. Powell, Aminochrome and related compounds, Progr. Med. Chem., 9: 275–339 (1972).
R. C. Sealy, C. C. Felix, J. S. Hyde, and H. M. Schwartz, Structure and reactivity of melanins: influence of free radicals and metal ions, in: Free Radicals in Biology, Vol. IV:209–259 (1980).
R. J. Bing, A. Siegal, A. Vitale, F. A. Balboni, E. Sparks M. Klapper and S. Edwards, Metabolic studies on the human heart in vivo, Am. J. Med., 15: 284–296 (1953).
L. H. Opie, Role of carnitine in fatty acid metabolism of normal and ischemic myocardium, Am. Heart, J., 97: 375–388 (1979)
S. Gudbjarnason, G. Oskarsdottir, B. Doell and J. Hallgrimsson, Myocardial membrane lipids in relation to cardiovascular disease, Adv. in Cardiol, 25:130–144 (1978).
S. Gudbjarnason, The use of glycolytic metabolism in the assessment of hypoxia in human hearts, Cardiol., 57: 35–46 (1972).
A. Lochner, J. C. N. Kotzé, L. Benade and W. Gevers, Mitochondrial oxidative phosphorylation in low-flow hypoxia, role of free fatty acids, J. Molec. Cell. Cardiol, 10: 857–875 (1978).
S. V. Pande and M. C. Blancher, Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl Coenzyme A esters, J. Biol. Chem. 246: 402–411 (1971).
R. A. Harris, B. Farmer and T. Ozawa, Inhibition of the mitochondrial adenine nucleotide transport system by oleoyl CoA, Archiv. Biochem. Biophys., 150: 199–209 (1972).
S. Gudbjarnason, P. Mathes and K. G. Ravens, Functional compartmentation of ATP and creatine phosphate in heart muscle, J. Molec. Cell. Cardiol, 1: 325–339 (1970).
S. Gudbjarnason, Inhibition of energy transfer in ischemic heart muscle, in: Recent advances in studies on cardiac structure and metabolism, E. Bajusz and G. Rona, ed., University Park Press, Baltimore, 1:17–26 (1972).
W. Kübler and P. G. Spieckermann, Regulation of glycolysis in the ischemic and anoxic myocardium, J. Molec. Cell. Cardiol., 1: 351–377 (1970).
A. M. Katz and H. H. Hecht, The early “pump” failure of the ischemic heart, Am. J. Med., 47: 497–502 (1969).
W. Kübler and A. M. Katz, Mechanism of early “pump” failure of the ischemic heart: Possible role of adenosine triphosphate depletion and inorganic phosphate accumulation, Am. J. Cardiol., 40: 467–471 (1977).
O. I. Bricknell and L. H. Opie, Glycolytic ATP and its production during ischemia in isolated Langendorff-perfused rat hearts, in: Recent advances in studies on cardiac structure and metabolism, T. Kobayashi, T. Sano and N. S. Dhalla ed., University Park Press, Baltimore, 11:505–519 (1978).
A. L. Shug, E. Shrago, N. Bittar, J. D. Folts and J. R. Kokes, Long chain fatty acyl CoA inhibition of adenine nucleotide translocase in the ischemic myocardium, Am. J. Physiol., 228: 689–692 (1975).
V. A. Saks, N. V. Lipina, V. N. Smiriov and E. I. Chazov, Studies of energy transport in heart cells. The functional coupling between mitochondrial creatine phosphokinase and ATP-ADP translocase, kinetic evidence, Archives Biochem. Biophys., 173: 34–41 (1976).
J. R. Neely, M. J. Rovetto, J. T. Whitmer and H. E. Morgan, Effects of ischemia on function and metabolism of the isolated working rat heart, Am. J. Physiol., 225: 651–658 (1973).
P. A. Poole-Wilson, Is early decline in cardiac function in ischemia due to carbon dioxide retention, Lancet, 2: 1285–1287 (1975).
J. R. Williamson, M. L. Woodrow and A. Scarpa, Calcium binding to cardiac sarcolemma, in: Recent advances in studies on cardiac sturcture and metabolism, A. Fleckenstein, and N. S. Dhalla, ed., University Park Press, Baltimore 61–71 (1975).
K. G. Ravens and S. Gudbjarnason, Changes in the activities of lysosomal enzymes in infarcted canine heart muscle, Circul. Res., 24: 851–856 (1969).
S. Gudbjarnason, C. De Schryver, C. Chiba, J. Yamanaka, and R. J. Bing, Protein and nucleic acid synthesis during the reparative processes following myocardial infarction, Circul. Res., 15: 320–326 (1964).
S. Gudbjarnason, K. G. Ravens and P. Mathes, Metabolic changes in infarcted and non-infarcted myocardium during the postinfarction period, in: Recent advances in studies on cardiac structure and metabolism, E. Bajusz and G. Rona, ed., University Park Press, Baltimore, 1:439–446 (1972).
K. G. Ravens, S. Gudbjarnason, C. Cowan and R. J. Bing, Gamma-glutamyl-transpeptidase in myocardial infarction, Circul., 39: 693–700 (1969).
S. Gudbjarnason, C. Cowan, W. Braasch and R. J. Bing, Changes in enzyme pattern of infarcted heart muscle during tissue repair, Cardiologia, 51. 148–159 (1967).
S. Gudbjarnason, C. Cowan and R. J. Bing, Increase in hexosemonophosphate shunt activity during tissue repair, Life Sciences, 6: 1093–1097 (1967).
S. Gudbjarnason, W. Braasch, C. Cowan and R. J. Bing, Metabolism of infarcted heart muscle during tissue repair, Am. J. Cardiol., 22: 360–369 (1968).
S. Gudbjarnason and D. Priver, LDH-isoenzymes in infarcted heart muscle, Life Sciences, 7: 623–627 (1968).
D. M. Dawson, T. L. Goodfriend and N. O. Kaplan, Lactic dehydrogenases-functions of the two types, rates of synthesis, Science 143:929–933 (1964).
S. Gudbjarnason, P. S. Puri and P. Mathes, Biochemical changes in non-infarcted heart muscle following myocardial infarction, J. Molec. Cellul. Cardiol., 2: 253–276 (1971).
E. Corday, L. Kaplan, S. Meerbaum, J. Brasch, C. Constantini, T. W. Lang, H. Gold, S. Rubins and I. Osher, Consequences of coronary arterial occlusion on remote myocardium: Effects of occlusion and reperfusion, Am. J. Cardiol., 36: 385–393 (1975).
A. M. Vikhert and N. M. Cherepachenko, Changes in metabolism of undamaged sections of myocardium following infarction, Circul. Res. 34, Suppl III, 182–191, (1974).
H. L. Wyatt, J. S. Forrester, P. L. da Luz, G. A. Diamond, R. Chagrasulis and H. J. Swan, Functional abnormalities in nonoccluded regions of myocardium after experimental coronary occlusion, Am. J. Cardiol. 37: 366–372 (1976).
P. Mathes and S. Gudbjarnason, Changes in norepinephrine stores in the canine heart following experimental myocardial infarction, Am. Heart J., 81: 211–219 (1971).
P. Mathes, C. Cowan and S. Gudbjarnason, Storage and metabolism of norepinephrine after experimental myocardial infarction, Am. J. Physiol, 220: 27–32 (1971).
R. F. Klein, W. G. Troyer, H. K. Thompson, M. D. Bogdonoff and A. G. Wallace, Catecholamine excretion in myocardial infarction, Arch. Int. Med., 122: 476–482 (1968).
G. Baumann, Abstract 8, in: Catecholamines and the heart, recent advances in experimental and clinical research., Munich, (1981).
S. Gudbjarnason, J. C. Fenton, P. L. Wolf and R. J. Bing, Stimulation of reparative processes following experimental myocardial infarction, Archiv. Int. Med., 118: 34–40 (1966).
L. H. Opie, Myocardial infarct size, Part 1, Basic consideratons, Am. Heart J., 100: 355–372 (1980).
L. H. Opie, Myocardial infarct size, Part 2, Comparison of antiinfarct effects of beta-blockade, glucose-insulin-potassium nitrates and hyaluronidase, Am. Heart J., 100: 531–550 (1980).
P. R. Maroko and E. Braunwald, Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion, Circul. 53 Suppl. I, 162–168 (1976).
P. R. Maroko, R. A. Kloner, T. Yasuda, L. G. T. Ribeiro, D. Maclean and E. Braunwald, Recent investigations on attempts to limit infarct size, in: Acute and long-term management of myocardial ischemia, A. Hjalmarsson and L. Wilhelmsen, ed., A. Lindgren and Söner AB, Mölndal, Sweden, 203–220 (1978).
S. Gudbjarnason, W. Braasch and R. J. Bing, Protein synthesis in cardiac hypertrophy and heart failure, in: Heart failure, Pathophysiological and clinical aspects, H. Reindell, J. Keul and E. Doll, ed, George Thieme Verlag, Stuttgart, 184–189 (1968).
R. Robert, V. de Mello and B. E. Sobel, Deleterious effects of methylprednisolone in patients with myocardial infarction, Circul. Res. Suppl. I, 1–204 (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Gudbjarnason, S., Hallgrimsson, J., Skuladottir, G., Emilsson, A., Gudmundsdottir, A. (1983). Myocardial Lipids in Relation to Coronary Artery Disease in Man. In: Peeters, H., Gresham, G.A., Paoletti, R. (eds) Arterial Pollution. NATO Advanced Science Institutes Series, vol 58. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4457-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4457-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4459-9
Online ISBN: 978-1-4684-4457-5
eBook Packages: Springer Book Archive